Cost Analysis of Three Techniques of Administering Sevoflurane

<div><svg height="12.9915pt" id="M36" style="vertical-align:-3.3136pt" version="1.1" viewbox="-0.0498162 -9.6779 30.9578 12.9915" width="30.9578pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0135,0,0,-0.0135,0,0)"><path d="M584 650H137L131 622C214 614 217 612 200 521L125 127C109 41 101 35 23 28L17 0H288L294 28C201 35 193 42 209 128L242 309H348C440 309 442 300 443 226H471L510 422H482C452 354 449 348 357 348H251L295 575C302 609 304 615 338 615H426C502 615 517 604 526 581C534 560 536 524 537 492L565 494C574 554 583 631 584 650Z" id="g113-71"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="607" vert-adv-y="607"></glyph.data></g><g transform="matrix(.0095,0,0,-0.0095,7.072,3.264)"><path d="M615 650H141L132 618C223 612 227 607 212 526L136 123C122 42 112 38 27 32L18 0H522C539 33 580 135 592 166L558 179C536 139 512 100 486 75C454 48 420 41 345 41C287 41 252 42 237 55C221 68 220 100 231 158L261 316H357C455 316 455 309 455 235H489L529 437H494C468 366 460 360 369 360H269L305 565C315 609 316 611 357 611H450C525 611 535 599 548 578C559 556 561 526 560 482L595 486L615 650Z" id="g50-70"></path><glyph.data ascent="3443" descent="-2856" horiz-adv-x="639" vert-adv-y="639"></glyph.data></g><g transform="matrix(.0135,0,0,-0.0135,13.501,0)"><path d="M368 703H309L44 -163H104L368 703Z" id="g113-48"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="412" vert-adv-y="412"></glyph.data></g><g transform="matrix(.0135,0,0,-0.0135,19.088,0)"><path d="M584 650H137L131 622C214 614 217 612 200 521L125 127C109 41 101 35 23 28L17 0H288L294 28C201 35 193 42 209 128L242 309H348C440 309 442 300 443 226H471L510 422H482C452 354 449 348 357 348H251L295 575C302 609 304 615 338 615H426C502 615 517 604 526 581C534 560 536 524 537 492L565 494C574 554 583 631 584 650Z" id="g113-71"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="607" vert-adv-y="607"></glyph.data></g><g transform="matrix(.0095,0,0,-0.0095,26.16,3.264)"><path d="M418 650H141L133 618C225 611 232 604 218 531L141 120C126 45 119 37 33 32L24 0H301L308 32C220 37 214 44 227 120L305 531C319 605 325 611 411 618L418 650Z" id="g50-74"></path><glyph.data ascent="3443" descent="-2856" horiz-adv-x="442" vert-adv-y="442"></glyph.data></g></svg> ratio versus time. <svg height="12.3115pt" id="M37" style="vertical-align:-3.31355pt" version="1.1" viewbox="-0.0498162 -8.99795 13.6269 12.3115" width="13.6269pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0135,0,0,-0.0135,0,0)"><path d="M584 650H137L131 622C214 614 217 612 200 521L125 127C109 41 101 35 23 28L17 0H288L294 28C201 35 193 42 209 128L242 309H348C440 309 442 300 443 226H471L510 422H482C452 354 449 348 357 348H251L295 575C302 609 304 615 338 615H426C502 615 517 604 526 581C534 560 536 524 537 492L565 494C574 554 583 631 584 650Z" id="g113-71"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="607" vert-adv-y="607"></glyph.data></g><g transform="matrix(.0095,0,0,-0.0095,7.072,3.264)"><path d="M615 650H141L132 618C223 612 227 607 212 526L136 123C122 42 112 38 27 32L18 0H522C539 33 580 135 592 166L558 179C536 139 512 100 486 75C454 48 420 41 345 41C287 41 252 42 237 55C221 68 220 100 231 158L261 316H357C455 316 455 309 455 235H489L529 437H494C468 366 460 360 369 360H269L305 565C315 609 316 611 357 611H450C525 611 535 599 548 578C559 556 561 526 560 482L595 486L615 650Z" id="g50-70"></path><glyph.data ascent="3443" descent="-2856" horiz-adv-x="639" vert-adv-y="639"></glyph.data></g></svg>: end-tidal concentration of sevoflurane and <svg height="12.3115pt" id="M38" style="vertical-align:-3.31355pt" version="1.1" viewbox="-0.0498162 -8.99795 11.8278 12.3115" width="11.8278pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0135,0,0,-0.0135,0,0)"><path d="M584 650H137L131 622C214 614 217 612 200 521L125 127C109 41 101 35 23 28L17 0H288L294 28C201 35 193 42 209 128L242 309H348C440 309 442 300 443 226H471L510 422H482C452 354 449 348 357 348H251L295 575C302 609 304 615 338 615H426C502 615 517 604 526 581C534 560 536 524 537 492L565 494C574 554 583 631 584 650Z" id="g113-71"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="607" vert-adv-y="607"></glyph.data></g><g transform="matrix(.0095,0,0,-0.0095,7.072,3.264)"><path d="M418 650H141L133 618C225 611 232 604 218 531L141 120C126 45 119 37 33 32L24 0H301L308 32C220 37 214 44 227 120L305 531C319 605 325 611 411 618L418 650Z" id="g50-74"></path><glyph.data ascent="3443" descent="-2856" horiz-adv-x="442" vert-adv-y="442"></glyph.data></g></svg>: inspired concentration of sevoflurane; Group L: low flow anaesthesia, Group A = alternative method of low flow anaesthesia, and Group V = volatile induction and maintenance of anaesthesia.</div>

Anesthesiology Research and Practice

Cost Analysis of Three Techniques of Administering Sevoflurane

Figure 2